Pharmaceutical personal care products (PPCPs) have increased in consumption due to the worldwide post-pandemic situation, marking them as chemical and pathogenic pollutants in significantly higher concentrations than ever in the ecosystem. Considering the inexplicable levels of these chemical residues discharged into the environment, concerns have been raised regarding their probable ecotoxicity to marine and terrestrial life. A further concern is the potential for developing and spreading antibiotic-resistant microorganisms and genes in aquatic ecosystems due to antibiotic exposure. Hence, knowing how these compounds impact aquatic ecosystem functioning is imperative, and thus is a critical area of research. The ecological risk analysis of PPCPs in aquatic ecosystems has been carried out using various strategies. Previous studies have reported numerous approaches for eliminating these PPCPs, including conventional treatment methods, activated sludge processes, generated wetlands, biological remediation, sequencing batch reactors, phytoremediation, and membrane bioreactors. In terms of green biotechnology approaches, the current research aims to discover effective procedures for removing PPCPs and their emerging resources as pollutants. Therefore, this review focuses on the over-extensive utilization of PPCPs and their emergent sources responsible for the contamination and environmental threat for future wastewater purposes. Further, as fungi and their enzymes and derivatives can remove pharmaceuticals and personal care products from wastewater through oxidation and several processes, they have attracted the attention of the scientific community due to their ability to remove PPCPs as pollutants and their status as emerging resources in wastewater. This review examines the fundamental approach and progress of the bioremediation of pharmaceutical- and personal-care-contaminated wastewater using fungal-based systems. It also discusses mechanistic approaches through hybridizing cultures and other biological systems with fungal strains, current technologies, and prospects for future research on PPCPs in wastewater treatment.
Nanotechnology is a swiftly expanding domain with significant applications across various disciplines. Platinum nanoparticles (PtNPs) represent a focal point in scientific investigations, drawing considerable research attention due to their potential applicability in diverse fields. Their inherent non-toxicity and remarkable stability confer distinctive plasmonic properties, rendering them particularly valuable in the realm of bioengineering. This review aims to comprehensively assess the ongoing global research landscape pertaining to the synthesis, mimicry, and utilization of PtNPs. The review covers the biosynthesis, as well as chemical and physical synthesis of PtNPs, incorporating both in-vivo and in-vitro experimental analyses. After their synthesis, a range of nanometrological characterization techniques is explored as analytical tools to facilitate the measurement of physical and chemical properties of nanoparticles. Additionally, the review delves into recent advancements in the functionalization of PtNPs for biomedical applications, encompassing areas such as nanomedicine, combination therapy, cancer treatment, and antibacterial properties.
Lassa fever, commonly known as Lassa hemorrhagic fever (LHF), is one of the progressive illnesses invading a large population of two to three million individuals in West Africa. The infection transmitted through the rodents severely impacts the local population and the medical professionals in surrounding areas, which were also the primary target of LHF. In epidemic areas, Lassa fever causes a public health threat since it poses a significant morbidity and fatality Case rate (CFR) ≥ 50%). The disease is widespread in West Africa and has developed into one of the most common and life-threatening viral hemorrhagic fevers. Monitoring and preventing persistent disease outbreaks has been challenging in affected regions due to insufficient healthcare facilities, diagnostics labs, care centers, and low socioeconomic conditions. An absence of public awareness and the emergence of an ecological niche is advantageous for the survival and multiplication of the mouse (Mastomys natalensis) inhabiting the Lassa virus serving as the disease's natural host and reservoir. The current review focuses on early diagnosis and appropriate treatment, highlighting the immediate requirement of clinically approved vaccines for LHF, causing preventative and control actions more difficult in the present era.